Tag: Antidepressants
Incident Psychotropic Use Down in Children in Second Quarter of 2020
Greatest decline in incident stimulant and anxiolytic/sedative-hypnotic medications was in quarter 2 of 2020
Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients
Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo
Relapse Risk Up With Antidepressant Therapy Discontinuation
Relapse occurred in fewer patients who maintained their antidepressant treatment versus those with discontinuation
Loneliness Linked to Use of High-Risk Meds in Seniors
Loneliness associated with use of NSAIDs, pain medicine, sedatives, anti-anxiety meds, and antidepressants
Antidepressant Use May Aid Outcomes in Depression and Diabetes
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Antidepressants May Work Better Than Exercise for Elderly Depression
Antidepressant therapy more effective than supervised physical activity at three and six months
AAN: Antidepressants Not Tied to Increased Intracerebral Hemorrhage Risk
Selective serotonin reuptake inhibitors are not associated with higher risk for intracerebral hemorrhage
Impact of Antidepressants Examined in Back Pain, Osteoarthritis
SNRIs have small, not clinically important effect on back pain; may have clinically important effect on osteoarthritis pain
